Meta-analysis of prevalence and risk factors of chronic obstructive pulmonary disease in China plateau_West China Medical Journal

Authors：

CHEN Yuting ¹ ,  HUANG Ling ² , XIA Junjie ² , QIU Yu ² , YI Ke ³ , WANG Jincheng ⁴ , CHEN Runjiao ¹ , XUE Haishi ¹

1. Clinical Medical College, Southwest Medical University, Luzhou, Sichuan 646000, P. R. China;
2. Department of Respiratory and Critical Care Medicine, the Third Hospital of Mianyang (Sichuan Mental Health Center), Mianyang, Sichuan 621054, P. R. China;
3. Department of Respiratory and Critical Care Medicine, Sichuan Science City Hospital, Mianyang, Sichuan 621054, P. R. China;
4. Department of Respiratory and Critical Care Medicine, People’s Hospital of Zhongjiang County, Deyang, Sichuan 618199, P. R. China;

Corresponding?author：

HUANG Ling, Email: 1721684460@qq.com

Keywords：

Chronic obstructive pulmonary disease; plateau; prevalence; epidemiology; meta-analysis

DOI：

10.7507/1002-0179.202212089

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To analyze the prevalence rate of chronic obstructive pulmonary disease in people over 40 years old in China plateau (altitude≥1 000 m) in recent years. Methods PubMed, Embase, Cochrane Library, China National Knowledge Infrastructure, WanFang Data, VIP databases and Chinese Medical Database were searched, and the articles published between January 1, 2010 and December 5, 2022 were collected. Two reviewers independently reviewed the literature, extracted data, and assessed the risk of bias of included articles. Meta-analysis was performed with Stata 17.1. Results A total of 13 articles were included, with a total sample size of 37 230 people, including 3 697 chronic obstructive pulmonary disease patients. The prevalence rate of chronic obstructive pulmonary disease in people over 40 years old in China plateau was 9.0% [95% confidence interval (0.07, 0.11), P<0.001]. The results of subgroup analysis showed that males (12.4%), smokers (13.4%), 61-70 years old (15.1%), primary school and below (10.3%), low body weight (12.2%) and Yunnan (11.5%) had the highest prevalence rates within the subgroup (P<0.05). Conclusions The prevalence of chronic obstructive pulmonary disease in China plateau is still high. Gender, age, smoking, education level, body mass index and region are still important influencing factors of chronic obstructive pulmonary disease.

Citation： CHEN Yuting, HUANG Ling, XIA Junjie, QIU Yu, YI Ke, WANG Jincheng, CHEN Runjiao, XUE Haishi. Meta-analysis of prevalence and risk factors of chronic obstructive pulmonary disease in China plateau. West China Medical Journal, 2023, 38(7): 1058-1064. doi: 10.7507/1002-0179.202212089 Copy

1.	Varmaghani M, Dehghani M, Heidari E, et al. Global prevalence of chronic obstructive pulmonary disease: systematic review and meta-analysis. East Mediterr Health J, 2019, 25(1): 47-57.
2.	Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol, 2010, 25(9): 603-605.
3.	劉嵐, 王旭明, 李錦波, 等. 云南省農村居民慢性阻塞性肺疾病患病現況及基于結構方程模型的影響因素. 中華疾病控制雜志, 2022, 26(11): 1332-1338.
4.	黃露, 王藝穎, 劉濤, 等. 貴州省 40 歲及以上人群慢性阻塞性肺疾病流行及影響因素. 中華疾病控制雜志, 2022, 26(5): 529-534, 553.
5.	王益德, 李爭, 徐丹, 等. 新疆墨玉縣鄉村地區慢性阻塞性肺疾病患病現況及影響因素分析. 第三軍醫大學學報, 2021, 43(22): 2485-2494.
6.	劉穎楠, 蔡樂, 王貴義, 等. 云南玉龍縣納西族居民慢性阻塞性肺疾病的患病現狀及影響因素分析. 現代預防醫學, 2020, 47(9): 1699-1702.
7.	關英, 阿選德. 西寧市 40 歲及以上居民慢性阻塞性肺病流行病學調查. 華南預防醫學, 2019, 45(5): 478-480.
8.	嘎瑪倉決, 李亞杰, 白國霞, 等. 2015 年西藏≥40 歲居民慢性阻塞性肺疾病流行病學調查. 中國公共衛生, 2019, 35(1): 104-106.
9.	李亞杰, 嘎瑪倉決, 索朗曲珍. 那曲縣≥40 歲居民慢性阻塞性肺疾病流行特征分析. 世界最新醫學信息文摘, 2018, 18(A0): 189, 191.
10.	邵英, 楊永芳, 秦明芳, 等. 云南省 40 歲及以上居民慢性阻塞性肺疾病流行情況及影響因素分析. 現代預防醫學, 2018, 45(20): 3654-3658.
11.	張銀娥, 吳婷婷, 馬麗霞, 等. 寧夏監測點居民慢性阻塞性肺疾病流行特征及危險因素調查分析. 中華疾病控制雜志, 2018, 22(3): 231-234.
12.	李玉璽, 王懷振, 商勇, 等. 維吾爾族人群慢性阻塞性肺疾病病因研究. 中國醫學工程, 2015, 23(12): 1-2, 4.
13.	張雅囡, 邱潔, 張錦, 等. 寧夏慢性阻塞性肺疾病危險因素流行病學調查. 中國實用內科雜志, 2013, 33(11): 876-880.
14.	張鑫, 劉翱, 李少瑩, 等. 昆明市慢性阻塞性肺疾病患病率及相關因素調查. 西南國防醫藥, 2013, 23(11): 1273-1274.
15.	榮艷, 凌敏, 胡翠芬, 等. 新疆阿克蘇農村地區慢性阻塞性肺疾病危險因素分析. 中國實用內科雜志, 2010, 30(6): 528-530.
16.	熊風, 賴玉清, 涂嘉欣, 等. 中國老年人群睡眠障礙流行特征的 Meta 分析. 中國循證醫學雜志, 2019, 19(4): 398-403.
17.	Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health study): a national cross-sectional study. Lancet, 2018, 391(10131): 1706-1717.
18.	Fang L, Gao P, Bao H, et al. Chronic obstructive pulmonary disease in China: a nationwide prevalence study. Lancet Respir Med, 2018, 6(6): 421-430.
19.	Xiong H, Huang Q, He C, et al. Prevalence of chronic obstructive pulmonary disease at high altitude: a systematic review and meta-analysis. PeerJ, 2020, 8: e8586.
20.	Laniado-Laborin R, Rendón A, Batiz F, et al. High altitude and chronic obstructive pulmonary disease prevalence: a casual or causal correlation?. Arch Bronconeumol, 2012, 48(5): 156-160.
21.	Horner A, Soriano JB, Puhan MA, et al. Altitude and COPD prevalence: analysis of the PREPOCOL-PLATINO-BOLD-EPI-SCAN study. Respir Res, 2017, 18(1): 162.
22.	Brakema EA, Tabyshova A, Kasteleyn MJ, et al. High COPD prevalence at high altitude: does household air pollution play a role?. Eur Respir J, 2019, 53(2): 1801193.
23.	Miele CH, Grigsby MR, Siddharthan T, et al. Environmental exposures and systemic hypertension are risk factors for decline in lung function. Thorax, 2018, 73(12): 1120-1127.
24.	Spelta F, Fratta Pasini AM, Cazzoletti L, et al. Body weight and mortality in COPD: focus on the obesity paradox. Eat Weight Disord, 2018, 23(1): 15-22.
25.	Wada H, Ikeda A, Maruyama K, et al. Low BMI and weight loss aggravate COPD mortality in men, findings from a large prospective cohort: the JACC study. Sci Rep, 2021, 11(1): 1531.

1. Varmaghani M, Dehghani M, Heidari E, et al. Global prevalence of chronic obstructive pulmonary disease: systematic review and meta-analysis. East Mediterr Health J, 2019, 25(1): 47-57.
2. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol, 2010, 25(9): 603-605.
3. 劉嵐, 王旭明, 李錦波, 等. 云南省農村居民慢性阻塞性肺疾病患病現況及基于結構方程模型的影響因素. 中華疾病控制雜志, 2022, 26(11): 1332-1338.
4. 黃露, 王藝穎, 劉濤, 等. 貴州省 40 歲及以上人群慢性阻塞性肺疾病流行及影響因素. 中華疾病控制雜志, 2022, 26(5): 529-534, 553.
5. 王益德, 李爭, 徐丹, 等. 新疆墨玉縣鄉村地區慢性阻塞性肺疾病患病現況及影響因素分析. 第三軍醫大學學報, 2021, 43(22): 2485-2494.
6. 劉穎楠, 蔡樂, 王貴義, 等. 云南玉龍縣納西族居民慢性阻塞性肺疾病的患病現狀及影響因素分析. 現代預防醫學, 2020, 47(9): 1699-1702.
7. 關英, 阿選德. 西寧市 40 歲及以上居民慢性阻塞性肺病流行病學調查. 華南預防醫學, 2019, 45(5): 478-480.
8. 嘎瑪倉決, 李亞杰, 白國霞, 等. 2015 年西藏≥40 歲居民慢性阻塞性肺疾病流行病學調查. 中國公共衛生, 2019, 35(1): 104-106.
9. 李亞杰, 嘎瑪倉決, 索朗曲珍. 那曲縣≥40 歲居民慢性阻塞性肺疾病流行特征分析. 世界最新醫學信息文摘, 2018, 18(A0): 189, 191.
10. 邵英, 楊永芳, 秦明芳, 等. 云南省 40 歲及以上居民慢性阻塞性肺疾病流行情況及影響因素分析. 現代預防醫學, 2018, 45(20): 3654-3658.
11. 張銀娥, 吳婷婷, 馬麗霞, 等. 寧夏監測點居民慢性阻塞性肺疾病流行特征及危險因素調查分析. 中華疾病控制雜志, 2018, 22(3): 231-234.
12. 李玉璽, 王懷振, 商勇, 等. 維吾爾族人群慢性阻塞性肺疾病病因研究. 中國醫學工程, 2015, 23(12): 1-2, 4.
13. 張雅囡, 邱潔, 張錦, 等. 寧夏慢性阻塞性肺疾病危險因素流行病學調查. 中國實用內科雜志, 2013, 33(11): 876-880.
14. 張鑫, 劉翱, 李少瑩, 等. 昆明市慢性阻塞性肺疾病患病率及相關因素調查. 西南國防醫藥, 2013, 23(11): 1273-1274.
15. 榮艷, 凌敏, 胡翠芬, 等. 新疆阿克蘇農村地區慢性阻塞性肺疾病危險因素分析. 中國實用內科雜志, 2010, 30(6): 528-530.
16. 熊風, 賴玉清, 涂嘉欣, 等. 中國老年人群睡眠障礙流行特征的 Meta 分析. 中國循證醫學雜志, 2019, 19(4): 398-403.
17. Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health study): a national cross-sectional study. Lancet, 2018, 391(10131): 1706-1717.
18. Fang L, Gao P, Bao H, et al. Chronic obstructive pulmonary disease in China: a nationwide prevalence study. Lancet Respir Med, 2018, 6(6): 421-430.
19. Xiong H, Huang Q, He C, et al. Prevalence of chronic obstructive pulmonary disease at high altitude: a systematic review and meta-analysis. PeerJ, 2020, 8: e8586.
20. Laniado-Laborin R, Rendón A, Batiz F, et al. High altitude and chronic obstructive pulmonary disease prevalence: a casual or causal correlation?. Arch Bronconeumol, 2012, 48(5): 156-160.
21. Horner A, Soriano JB, Puhan MA, et al. Altitude and COPD prevalence: analysis of the PREPOCOL-PLATINO-BOLD-EPI-SCAN study. Respir Res, 2017, 18(1): 162.
22. Brakema EA, Tabyshova A, Kasteleyn MJ, et al. High COPD prevalence at high altitude: does household air pollution play a role?. Eur Respir J, 2019, 53(2): 1801193.
23. Miele CH, Grigsby MR, Siddharthan T, et al. Environmental exposures and systemic hypertension are risk factors for decline in lung function. Thorax, 2018, 73(12): 1120-1127.
24. Spelta F, Fratta Pasini AM, Cazzoletti L, et al. Body weight and mortality in COPD: focus on the obesity paradox. Eat Weight Disord, 2018, 23(1): 15-22.
25. Wada H, Ikeda A, Maruyama K, et al. Low BMI and weight loss aggravate COPD mortality in men, findings from a large prospective cohort: the JACC study. Sci Rep, 2021, 11(1): 1531.

West China Medical Journal

Meta-analysis of prevalence and risk factors of chronic obstructive pulmonary disease in China plateau

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content